Exposure to Paxil/Paxil CR (paroxetine HCl, GlaxoSmithKline) during the first trimester of pregnancy increases the risk for congenital malformations, especially cardiac malformations, according to the FDA. As a result, the manufacturer has changed Paxil's pregnancy category from C to D and added new recommendations to the prescribing information's Warnings section.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.